HOME >> BIOLOGY >> NEWS
Hawaii's anthurium growers cope with plant disease

A destructive pathogen is impacting Hawaii's production of anthuriums, a plant known for its heart-shaped flower and leaves, say plant pathologists with The American Phytopathological Society (APS).

Anthuriums's flower portion, or spathe, is available in a variety of colors including brilliant shades of red, orange, pink, and salmon. Although they originated in Central America, anthuriums are now the most important cut flowers in the Hawaiian floriculture industry, said Anne Alvarez, Department of Plant and Environmental Protection Sciences, University of Hawaii, Honolulu, HI. In 2004, Hawaii's cut flower sales were valued at $13.1 million, with anthuriums ranking as the top seller at $4.7 million. At the peak of production in the early 1980s, Hawaii was supplying up to 232,000 dozen flowers per month to the world.

Anthurium production levels have been significantly reduced due to bacterial blight caused by the bacterial pathogen Xanthomonas axonopodis pv. dieffenbachiae. This disease was first reported in Kauai, HI in 1971 but had little impact on the industry until 1981 when plants began to die in large numbers on farms in Hilo, HI. "Once introduced into a new growing area, bacterial blight may result in 50-100 percent loss of plants," said Alvarez.

The disease reached epidemic proportions during 1985-1989, destroying the production of approximately 200 small farms existent in Hawaii at the time. During the 1980s, Hawaii's anthurium production dropped from a record high of approximately 30 million stems to 15.6 million stems in 1990. Following implementation of an integrated disease management program, losses were eventually reduced to five percent or less, Alvarez said.

Various components of an integrated disease management program for anthurium blight include sanitation, disinfection of harvesting containers, chemical sprays, modification of cultural practices, production of pathogen-free planting stocks in vitro, use of resi
'"/>

Contact: Amy Steigman
asteigman@scisoc.org
651-994-3802
American Phytopathological Society
1-Mar-2006


Page: 1 2

Related biology news :

1. Hanging baskets of sex and death help fruit growers
2. Circadian clock controls plant growth hormone
3. New system of wastewater treatment could reduce the size of treatment plants by half
4. First case of successful ovarian tissue transplantation between two, nonidentical sisters
5. Discovery in plant virus may help prevent HIV and similar viruses
6. US Department of Defense awards $1.6 million for implantable biochip research
7. News conference on plant diseases and issues important to California
8. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
9. Isoprene emission from plants -- a volatile answer to heat stress
10. Brains hearing center may reorganize after implant of cochlear device
11. Implanon, Norplant and Jadelle are all effective contraceptives -- but side effects vary

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hawaii anthurium growers cope with plant disease

(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
(Date:5/27/2015)... , May 27, 2015  Two years after its ... hackers and citizen scientists, Oakland -based ... campaign promoting its mission to democratize science through a ... Photo ... Based out of the new ...
(Date:5/27/2015)... 2015 ­ Caris Life Sciences®, a leading ... medicine, today announced it has appointed the Levine Cancer ... excellence site in the Caris Centers of Excellence for ... Institute is one of the largest cancer care providers ... cancer patients annually. Derek Raghavan , M.D., Ph.D., ...
(Date:5/26/2015)... , Kalifornien und HILDEN, Deutschland, May 26, ... Clinical Insight ®   ... und die Erstellung dazugehöriger Berichte; Vorstellung auf ... QIAGEN N.V. (NASDAQ: QGEN ... die Markteinführung von QIAGEN Clinical Insight ® ...
(Date:5/26/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), ... modernized traditional Chinese medicine (mTCM), branded generics and active ... of Shareholders for fiscal year ended June 30, 2014 ... office located in Chengdu, China ... in Chengdu, China ) on May ...
Breaking Biology Technology:East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
Cached News: